Global and United States Autologous Stem Cell Based Therapies Market Report & Forecast 2023-2028

Report ID: 1808212 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Autologous Stem Cell Based Therapies Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Autologous Stem Cell Based Therapies Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Autologous Stem Cell Based Therapies Market Size for the Year 2017-2028
        1.2.2 Global Autologous Stem Cell Based Therapies Market Size for the Year 2017-2028
    1.3 Autologous Stem Cell Based Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Autologous Stem Cell Based Therapies in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Autologous Stem Cell Based Therapies Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Autologous Stem Cell Based Therapies Market Dynamics
        1.4.1 Autologous Stem Cell Based Therapies Industry Trends
        1.4.2 Autologous Stem Cell Based Therapies Market Drivers
        1.4.3 Autologous Stem Cell Based Therapies Market Challenges
        1.4.4 Autologous Stem Cell Based Therapies Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Autologous Stem Cell Based Therapies by Type
    2.1 Autologous Stem Cell Based Therapies Market Segment by Type
        2.1.1 Embryonic Stem Cell
        2.1.2 Resident Cardiac Stem Cells
        2.1.3 Umbilical Cord Blood Stem Cells
    2.2 Global Autologous Stem Cell Based Therapies Market Size by Type (2017, 2022 & 2028)
    2.3 Global Autologous Stem Cell Based Therapies Market Size by Type (2017-2028)
    2.4 United States Autologous Stem Cell Based Therapies Market Size by Type (2017, 2022 & 2028)
    2.5 United States Autologous Stem Cell Based Therapies Market Size by Type (2017-2028)
3 Autologous Stem Cell Based Therapies by Application
    3.1 Autologous Stem Cell Based Therapies Market Segment by Application
        3.1.1 Neurodegenerative Disorders
        3.1.2 Autoimmune Diseases
        3.1.3 Cardiovascular Diseases
    3.2 Global Autologous Stem Cell Based Therapies Market Size by Application (2017, 2022 & 2028)
    3.3 Global Autologous Stem Cell Based Therapies Market Size by Application (2017-2028)
    3.4 United States Autologous Stem Cell Based Therapies Market Size by Application (2017, 2022 & 2028)
    3.5 United States Autologous Stem Cell Based Therapies Market Size by Application (2017-2028)
4 Global Autologous Stem Cell Based Therapies Competitor Landscape by Company
    4.1 Global Autologous Stem Cell Based Therapies Market Size by Company
        4.1.1 Top Global Autologous Stem Cell Based Therapies Companies Ranked by Revenue (2021)
        4.1.2 Global Autologous Stem Cell Based Therapies Revenue by Player (2017-2022)
    4.2 Global Autologous Stem Cell Based Therapies Concentration Ratio (CR)
        4.2.1 Autologous Stem Cell Based Therapies Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Autologous Stem Cell Based Therapies in 2021
        4.2.3 Global Autologous Stem Cell Based Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Autologous Stem Cell Based Therapies Headquarters, Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Autologous Stem Cell Based Therapies Headquarters and Area Served
        4.3.2 Global Autologous Stem Cell Based Therapies Companies Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Autologous Stem Cell Based Therapies Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Autologous Stem Cell Based Therapies Market Size by Company
        4.5.1 Top Autologous Stem Cell Based Therapies Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Autologous Stem Cell Based Therapies Revenue by Players (2020, 2021 & 2022)
5 Global Autologous Stem Cell Based Therapies Market Size by Region
    5.1 Global Autologous Stem Cell Based Therapies Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Autologous Stem Cell Based Therapies Market Size by Region (2017-2028)
        5.2.1 Global Autologous Stem Cell Based Therapies Market Size by Region: 2017-2022
        5.2.2 Global Autologous Stem Cell Based Therapies Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Autologous Stem Cell Based Therapies Market Size YoY Growth 2017-2028
        6.1.2 North America Autologous Stem Cell Based Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Autologous Stem Cell Based Therapies Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Autologous Stem Cell Based Therapies Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Autologous Stem Cell Based Therapies Market Size YoY Growth 2017-2028
        6.3.2 Europe Autologous Stem Cell Based Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Autologous Stem Cell Based Therapies Market Size YoY Growth 2017-2028
        6.4.2 Latin America Autologous Stem Cell Based Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Autologous Stem Cell Based Therapies Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Autologous Stem Cell Based Therapies Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Regeneus
        7.1.1 Regeneus Company Details
        7.1.2 Regeneus Business Overview
        7.1.3 Regeneus Autologous Stem Cell Based Therapies Introduction
        7.1.4 Regeneus Revenue in Autologous Stem Cell Based Therapies Business (2017-2022)
        7.1.5 Regeneus Recent Development
    7.2 Mesoblast
        7.2.1 Mesoblast Company Details
        7.2.2 Mesoblast Business Overview
        7.2.3 Mesoblast Autologous Stem Cell Based Therapies Introduction
        7.2.4 Mesoblast Revenue in Autologous Stem Cell Based Therapies Business (2017-2022)
        7.2.5 Mesoblast Recent Development
    7.3 Pluristem Therapeutics Inc
        7.3.1 Pluristem Therapeutics Inc Company Details
        7.3.2 Pluristem Therapeutics Inc Business Overview
        7.3.3 Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Introduction
        7.3.4 Pluristem Therapeutics Inc Revenue in Autologous Stem Cell Based Therapies Business (2017-2022)
        7.3.5 Pluristem Therapeutics Inc Recent Development
    7.4 US STEM CELL, INC.
        7.4.1 US STEM CELL, INC. Company Details
        7.4.2 US STEM CELL, INC. Business Overview
        7.4.3 US STEM CELL, INC. Autologous Stem Cell Based Therapies Introduction
        7.4.4 US STEM CELL, INC. Revenue in Autologous Stem Cell Based Therapies Business (2017-2022)
        7.4.5 US STEM CELL, INC. Recent Development
    7.5 Brainstorm Cell Therapeutics
        7.5.1 Brainstorm Cell Therapeutics Company Details
        7.5.2 Brainstorm Cell Therapeutics Business Overview
        7.5.3 Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Introduction
        7.5.4 Brainstorm Cell Therapeutics Revenue in Autologous Stem Cell Based Therapies Business (2017-2022)
        7.5.5 Brainstorm Cell Therapeutics Recent Development
    7.6 Tigenix
        7.6.1 Tigenix Company Details
        7.6.2 Tigenix Business Overview
        7.6.3 Tigenix Autologous Stem Cell Based Therapies Introduction
        7.6.4 Tigenix Revenue in Autologous Stem Cell Based Therapies Business (2017-2022)
        7.6.5 Tigenix Recent Development
    7.7 Med cell Europe
        7.7.1 Med cell Europe Company Details
        7.7.2 Med cell Europe Business Overview
        7.7.3 Med cell Europe Autologous Stem Cell Based Therapies Introduction
        7.7.4 Med cell Europe Revenue in Autologous Stem Cell Based Therapies Business (2017-2022)
        7.7.5 Med cell Europe Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Autologous Stem Cell Based Therapies Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Autologous Stem Cell Based Therapies Market Trends
    Table 3. Autologous Stem Cell Based Therapies Market Drivers
    Table 4. Autologous Stem Cell Based Therapies Market Challenges
    Table 5. Autologous Stem Cell Based Therapies Market Restraints
    Table 6. Global Autologous Stem Cell Based Therapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Autologous Stem Cell Based Therapies Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Autologous Stem Cell Based Therapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Autologous Stem Cell Based Therapies Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Autologous Stem Cell Based Therapies Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Autologous Stem Cell Based Therapies Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Autologous Stem Cell Based Therapies Revenue Share by Player, 2017-2022
    Table 13. Global Autologous Stem Cell Based Therapies Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Autologous Stem Cell Based Therapies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autologous Stem Cell Based Therapies as of 2021)
    Table 15. Top Players of Autologous Stem Cell Based Therapies in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Autologous Stem Cell Based Therapies Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Autologous Stem Cell Based Therapies Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Autologous Stem Cell Based Therapies Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Autologous Stem Cell Based Therapies Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Autologous Stem Cell Based Therapies Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Autologous Stem Cell Based Therapies Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Autologous Stem Cell Based Therapies Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Autologous Stem Cell Based Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Autologous Stem Cell Based Therapies Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Autologous Stem Cell Based Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Autologous Stem Cell Based Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Autologous Stem Cell Based Therapies Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Regeneus Company Details
    Table 31. Regeneus Business Overview
    Table 32. Regeneus Autologous Stem Cell Based Therapies Product
    Table 33. Regeneus Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million)
    Table 34. Regeneus Recent Development
    Table 35. Mesoblast Company Details
    Table 36. Mesoblast Business Overview
    Table 37. Mesoblast Autologous Stem Cell Based Therapies Product
    Table 38. Mesoblast Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million)
    Table 39. Mesoblast Recent Development
    Table 40. Pluristem Therapeutics Inc Company Details
    Table 41. Pluristem Therapeutics Inc Business Overview
    Table 42. Pluristem Therapeutics Inc Autologous Stem Cell Based Therapies Product
    Table 43. Pluristem Therapeutics Inc Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million)
    Table 44. Pluristem Therapeutics Inc Recent Development
    Table 45. US STEM CELL, INC. Company Details
    Table 46. US STEM CELL, INC. Business Overview
    Table 47. US STEM CELL, INC. Autologous Stem Cell Based Therapies Product
    Table 48. US STEM CELL, INC. Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million)
    Table 49. US STEM CELL, INC. Recent Development
    Table 50. Brainstorm Cell Therapeutics Company Details
    Table 51. Brainstorm Cell Therapeutics Business Overview
    Table 52. Brainstorm Cell Therapeutics Autologous Stem Cell Based Therapies Product
    Table 53. Brainstorm Cell Therapeutics Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million)
    Table 54. Brainstorm Cell Therapeutics Recent Development
    Table 55. Tigenix Company Details
    Table 56. Tigenix Business Overview
    Table 57. Tigenix Autologous Stem Cell Based Therapies Product
    Table 58. Tigenix Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million)
    Table 59. Tigenix Recent Development
    Table 60. Med cell Europe Company Details
    Table 61. Med cell Europe Business Overview
    Table 62. Med cell Europe Autologous Stem Cell Based Therapies Product
    Table 63. Med cell Europe Revenue in Autologous Stem Cell Based Therapies Business (2017-2022) & (US$ Million)
    Table 64. Med cell Europe Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Autologous Stem Cell Based Therapies Product Picture
    Figure 2. Global Autologous Stem Cell Based Therapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Autologous Stem Cell Based Therapies Market Size 2017-2028 (US$ Million)
    Figure 4. United States Autologous Stem Cell Based Therapies Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Autologous Stem Cell Based Therapies Market Size 2017-2028 (US$ Million)
    Figure 6. United States Autologous Stem Cell Based Therapies Market Share in Global 2017-2028
    Figure 7. Autologous Stem Cell Based Therapies Report Years Considered
    Figure 8. Product Picture of Embryonic Stem Cell
    Figure 9. Product Picture of Resident Cardiac Stem Cells
    Figure 10. Product Picture of Umbilical Cord Blood Stem Cells
    Figure 11. Global Autologous Stem Cell Based Therapies Market Share by Type in 2022 & 2028
    Figure 12. Global Autologous Stem Cell Based Therapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Autologous Stem Cell Based Therapies Market Share by Type (2017-2028)
    Figure 14. United States Autologous Stem Cell Based Therapies Market Share by Type in 2022 & 2028
    Figure 15. United States Autologous Stem Cell Based Therapies Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Autologous Stem Cell Based Therapies Market Share by Type (2017-2028)
    Figure 17. Product Picture of Neurodegenerative Disorders
    Figure 18. Product Picture of Autoimmune Diseases
    Figure 19. Product Picture of Cardiovascular Diseases
    Figure 20. Global Autologous Stem Cell Based Therapies Market Share by Application in 2022 & 2028
    Figure 21. Global Autologous Stem Cell Based Therapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Autologous Stem Cell Based Therapies Market Share by Application (2017-2028)
    Figure 23. United States Autologous Stem Cell Based Therapies Market Share by Application in 2022 & 2028
    Figure 24. United States Autologous Stem Cell Based Therapies Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Autologous Stem Cell Based Therapies Market Share by Application (2017-2028)
    Figure 26. North America Autologous Stem Cell Based Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Autologous Stem Cell Based Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Autologous Stem Cell Based Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Autologous Stem Cell Based Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Autologous Stem Cell Based Therapies Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Autologous Stem Cell Based Therapies Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Regeneus Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2017-2022)
    Figure 55. Mesoblast Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2017-2022)
    Figure 56. Pluristem Therapeutics Inc Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2017-2022)
    Figure 57. US STEM CELL, INC. Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2017-2022)
    Figure 58. Brainstorm Cell Therapeutics Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2017-2022)
    Figure 59. Tigenix Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2017-2022)
    Figure 60. Med cell Europe Revenue Growth Rate in Autologous Stem Cell Based Therapies Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Regeneus
Mesoblast
Pluristem Therapeutics Inc
US STEM CELL, INC.
Brainstorm Cell Therapeutics
Tigenix
Med cell Europe
Frequently Asked Questions
Autologous Stem Cell Based Therapies report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Autologous Stem Cell Based Therapies report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Autologous Stem Cell Based Therapies report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Car Electric Horn

Car Electric Horn market is segmented by region (country), players, by Type and by Application. P ... Read More